Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...

Industrial Gases Market worth $126,526.8 million by 2030 at 5.1%, says MarketsandMarkets™

In terms of value, the Industrial Gases Market projected to be worth USD 126,526.8 million by 2030, registering a CAGR of 5.1 ...
News-Medical.Net on MSN

Unveiling IDH-mutant glioma's roots: A new path for early diagnosis

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50.

Understanding Business Logic: Key Concepts and Examples

Learn how business logic serves as the framework of rules and algorithms, enabling smooth data flow between databases and ...

AZZ, Inc.: AZZ Inc. Reports Fiscal Year 2026 Third Quarter Results

Operational Strength Drives Sales, EPS, Cash Flow Growth and Value Creation Fiscal Year 2026 Guidance Narrowed FORT WORTH, Texas, January 7, 2026 /PRNewswire/ -- ...